45.80000 EUR
1.8
4.09%
Last update Dec 15, 8:00 AM CET
Main market
Day range
45.80000
45.80000
Previous close
44
Open
45.80000
Access this stock data via API
Subscribe
Nektar Therapeutics Inc.
45.80
1.80
4.09%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024
Total reported revenue 83.8M
Cost of revenue 26.1M
Gross profit 57.7M
Operating expense
Research & development 103.0M
Selling general and admin 65.4M
Other operating expenses
Operating income -110.7M
Non operating interest income
Income 12.4M
Expense 23.9M
Other income expense 20.7M
Pretax income -101.5M
Tax provision -203.6K
Net income -101.3M
Basic EPS -8.7
Diluted EPS -8.7
Basic average shares 11.7M
Diluted average shares 11.7M
EBITDA -94.9M
Net income from continuing op. -101.3M
Minority interests
Preferred stock dividends
Access /income_statement data via our API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 5 hours 36 minutes

14:23
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).